Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $104.45 USD
Change Today +0.24 / 0.23%
Volume 849.4K
INCY On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - incyte corp (INCY)

NameBoard RelationshipsTitleAge
Herve Hoppenot 6 RelationshipsChief Executive Officer, President, Director and Member of Non-Management Stock Option Committee54
Roy A. Whitfield 45 RelationshipsCo-Founder61
David W. Gryska MBA19 RelationshipsChief Financial Officer and Executive Vice President60
Barry P. Flannelly Pharm.D., MBANo RelationshipsExecutive Vice President and General Manager of U.S.--
Reid M. Huber Ph.D.10 RelationshipsChief Scientific Officer and Executive Vice President43

Board Members - incyte corp (INCY)

NameBoard RelationshipsPrimary CompanyAge
Herve Hoppenot 6 RelationshipsIncyte Corporation54
Julian C. Baker 51 RelationshipsIdera Pharmaceuticals, Inc.48
Paul A. Brooke 30 RelationshipsvenBio LLC70
Paul A. Friedman M.D.74 RelationshipsCerulean Pharma Inc.72
Wendy L. Dixon Ph.D.67 RelationshipsAlkermes plc60

Executive Committees* - incyte corp (INCY)

Committee NameChairpersonBoard RelationshipsMembers
Compensation CommitteePaul A. Brooke 30 Relationships2 Executives
Nominating CommitteeJulian C. Baker 51 Relationships3 Executives
Corporate Governance CommitteeJulian C. Baker 51 Relationships3 Executives
Finance CommitteePaul A. Brooke 30 Relationships3 Executives
View INCY Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $104.45 USD +0.24

INCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $64.77 USD +0.43
ARIAD Pharmaceuticals Inc $8.09 USD -0.18
BioMarin Pharmaceutical Inc $136.73 USD -0.05
Jazz Pharmaceuticals PLC $177.13 USD +1.06
Vertex Pharmaceuticals Inc $126.19 USD +2.71
View Industry Companies
 

Industry Analysis

INCY

Industry Average

Valuation INCY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.